6P5M

Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent


Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.


Version NumberVersion DateVersion Type/Reason Version ChangeRevised CIF Category
1.02020-01-15Initial release
1.12020-02-26Database referencescitation, citation_author
1.22023-10-11Data collection, Database references, Refinement descriptionchem_comp_atom, chem_comp_bond, database_2, pdbx_initial_refinement_model, struct_ncs_dom_lim Download